Intractable Discogenic Low Back Pain Without Neurological Deficit — Should I Have a Steroid Injection, Ozone Disc Nucleolysis, or Spine Surgery?

If you are sitting with chronic back pain that has not responded to physiotherapy, rest, or painkillers — and your doctor has mentioned either injections, an ozone procedure, or surgery — you are likely feeling overwhelmed. Three very different options. Three very different risk profiles. And often, not enough time in the consultation to fully understand which is right for you and in what order.

I see this pattern every week in clinic. Patients arrive having been handed a surgical referral — sometimes after just one or two steroid injections — without anyone explaining that there is a structured, evidence-based pathway between "basic injections" and "going under the knife." That pathway includes ozone disc nucleolysis, a minimally invasive, day-case procedure that, in the right patient, can eliminate the need for surgery entirely.

This guide compares all three options honestly — their mechanisms, their success rates, their risks, and critically, the order in which they should be considered when you have intractable back or leg pain but no neurological deficit (no foot drop, no motor weakness, no bladder or bowel symptoms).

The intervertebral disc — the shock-absorbing cushion between your vertebrae — has a tough outer ring (annulus fibrosus) and a soft gel-like centre (nucleus pulposus). When the disc herniates or degenerates, the gel bulges outward and presses on a nearby nerve root. The result: back pain, leg pain (sciatica), burning, numbness, or all of the above.

The disc's problem is not just mechanical compression. The herniated material is chemically irritating — it releases inflammatory substances (phospholipase A2, substance P, cytokines) that drive nerve inflammation independently of any physical pressure. This is why patients can have significant pain even from a relatively small herniation, and why some people with large herniations feel little pain at all.

Three interventions address this problem — but at three very different levels:

Option A: Epidural steroid injection (ESI / TFESI)

A corticosteroid (usually methylprednisolone or dexamethasone) is delivered via needle into the epidural space — the narrow canal surrounding the spinal cord and nerve roots. It does not touch the disc itself. What it does is reduce the inflammatory swelling around the compressed nerve, providing pain relief and improved function during the healing phase. When performed as a transforaminal injection (TFESI), the steroid is delivered precisely to the affected nerve root level under fluoroscopy (live X-ray) guidance.

Steroid injections are excellent at what they do: they calm the fire quickly, allow physiotherapy to progress, and in early, acute radiculopathy, sometimes buy enough time for the disc to resolve naturally. The problem arises when they are used repeatedly as a long-term strategy — which they were never designed for.

Option B: Ozone disc nucleolysis (intradiscal O₂–O₃ injection)

Ozone disc nucleolysis works at the source — inside the disc itself. A precisely calibrated mixture of oxygen and ozone (O₂–O₃) gas, at a concentration of 27–30 micrograms per millilitre, is injected directly into the disc nucleus under fluoroscopy guidance. Ozone is a powerful oxidising agent: it breaks down the proteoglycan molecules that give the nucleus its water-retaining, gel-like structure. The disc nucleus dehydrates, shrinks, and retracts — physically reducing the bulge that is compressing the nerve root.

Simultaneously, a periradicular injection of ozone with a small amount of local anaesthetic is delivered around the affected nerve root, addressing the inflammatory component. The entire procedure takes 30–45 minutes; patients are discharged home the same day. There are no incisions, no implants, and no general anaesthesia. Ozone reverts to ordinary oxygen within approximately 45 minutes — leaving no foreign substance in the body.

Option C: Spinal surgery (microdiscectomy or lumbar fusion)

Surgery physically removes the offending disc material (discectomy) or stabilises an unstable spinal segment (fusion). When neurological deficit is present — foot drop, progressive leg weakness, or cauda equina syndrome — surgery is urgent and unambiguous. For pain-only patients, however, the evidence is considerably less compelling, and the risk of long-term surgical failure is frequently underappreciated.

Everything discussed above applies to patients with pain as their dominant — and only — symptom. Surgery becomes urgent and appropriate when any of the following are present:

• Cauda equina syndrome — loss of bladder or bowel control, saddle anaesthesia. This is a surgical emergency.
• Progressive motor weakness — foot drop, worsening leg weakness despite treatment.
• Rapidly escalating neurological deficit — numbness or weakness spreading or worsening week on week.
• Large sequestrated disc fragment with significant cord or cauda equina compression on MRI.

Similarly, ozone disc nucleolysis is not appropriate for: severely collapsed discs (Pfirrmann grade V, >2/3 height loss), active spinal infection, uncontrolled hyperthyroidism, or large migrated/sequestrated fragments. A thorough MRI review and clinical assessment by a specialist is mandatory before any procedure.

Here is the part of the surgical conversation that rarely happens in the pre-operative consultation. When back surgery fails — and it does in 20–46% of cases — the result is a condition called Failed Back Surgery Syndrome (FBSS). The International Association for the Study of Pain defines it as persistent lumbar or radicular pain following spinal surgery in the same topographical location — pain that is either unchanged, worsened, or entirely new.

The dominant mechanism behind FBSS is epidural fibrosis — dense scar tissue that forms in the epidural space after surgery. Think of it this way: surgery is a controlled injury to the spine. As the body heals, it lays down collagen fibres to repair the disrupted tissue. In some patients, this scarring becomes excessive, wrapping around the nerve roots like cling-film around a live wire — compressing them, restricting their blood supply, and generating constant pain signals that have nothing to do with any remaining disc problem. The surgical target may have been perfectly addressed; it is the aftermath that creates the new pain.

Repeat surgery for FBSS is not the answer. Each subsequent operation carries higher complication rates, more fibrosis, and lower success — spinal instability rises from 12% after the first reoperation to 50% after the fourth. What FBSS patients need is a specialist minimally invasive procedure that goes directly to the scar tissue — and that procedure is epidural adhesiolysis.

Epidural adhesiolysis (Racz neuroplasty / epidurolysis) — the IBAP Clinics approach

Epidural adhesiolysis was developed by Dr Gabor Racz in the late 1980s and remains the most evidence-supported minimally invasive intervention for FBSS. At IBAP Clinics, the procedure is performed as a day case under fluoroscopy guidance. Here is what happens:

The catheter — a flexible, spring-guided instrument — is introduced through the caudal epidural space and navigated under live fluoroscopy to the exact level and side of the confirmed fibrosis. A contrast epidurogram first maps the adhesion by showing where the contrast dye fails to flow freely — the "filling defect" that identifies the scar. The catheter is then steered to that point. The procedure delivers:

• Hyaluronidase — an enzyme that specifically dissolves the hyaluronic acid bonds in fibrous adhesions, breaking down the scar tissue matrix
• Hypertonic saline — reduces oedema around the compressed nerve root and provides a prolonged analgesic effect
• Local anaesthetic — immediate nerve-root pain relief and diagnostic confirmation of the target
• Corticosteroid — reduces residual neuroinflammation at the adhesion site

For complex cases with dense or multi-level fibrosis, epiduroscopy is available — a fibre-optic camera is introduced into the epidural space to directly visualise the adhesions before and after lysis, allowing real-time confirmation of successful scar disruption.